Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07749716 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata

Name: Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata — clinical trial record (NCT07749716)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorJiangsu vcare pharmaceutical technology co., LTD

Started2026-08-18

View on ClinicalTrials.gov ↗

Amendment history

2026-08-25

Study Status, Contacts/Locations v1

Recruitment opened

Start dateestimated 2026-08-15→confirmed 2026-08-18

Study sitesdetails revised at 1 of 1 site

2026-08-03

Original filing

Jiangsu vcare pharmaceutical technology co., LTD

17 trials monitored

See all monitored trials

This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the efficacy and safety of VC005 tablets in subjects with severe alopecia areata (AA).

Trial Details

NCT Number	NCT07749716
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Alopecia Areata
Enrollment	120 participants
Start Date	2026-08-18
Primary Completion	2028-12-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-27